Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Proliferation index: a continuous model to predict prognosis in patients with tumours of the Ewing's sarcoma family.

Brownhill S, Cohen D, Burchill S.

PLoS One. 2014 Aug 26;9(8):e104106. doi: 10.1371/journal.pone.0104106. eCollection 2014.

2.

Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.

Biswas B, Rastogi S, Khan SA, Shukla NK, Deo SV, Agarwala S, Sharma DN, Thulkar S, Vishnubhatla S, Pathania S, Bakhshi S.

Clin Oncol (R Coll Radiol). 2014 Nov;26(11):722-9. doi: 10.1016/j.clon.2014.05.006. Epub 2014 Jun 8.

PMID:
24919857
3.

A systematic review of molecular and biological markers in tumours of the Ewing's sarcoma family.

Riley RD, Burchill SA, Abrams KR, Heney D, Sutton AJ, Jones DR, Lambert PC, Young B, Wailoo AJ, Lewis IJ.

Eur J Cancer. 2003 Jan;39(1):19-30. Review.

PMID:
12504654
4.

Apoptotic responsiveness of the Ewing's sarcoma family of tumours to tumour necrosis factor-related apoptosis-inducing ligand (TRAIL).

Van Valen F, Fulda S, Truckenbrod B, Eckervogt V, Sonnemann J, Hillmann A, Rödl R, Hoffmann C, Winkelmann W, Schäfer L, Dockhorn-Dworniczak B, Wessel T, Boos J, Debatin KM, Jürgens H.

Int J Cancer. 2000 Oct 15;88(2):252-9.

5.

Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.

Brownhill SC, Taylor C, Burchill SA.

Br J Cancer. 2007 Jun 18;96(12):1914-23. Epub 2007 May 29.

6.

Ewing's sarcoma family tumours. Differences in clinicopathological characteristics at presentation between localised and metastatic tumours.

Bacci G, Balladelli A, Forni C, Longhi A, Serra M, Fabbri N, Alberghini M, Ferrari S, Benassi MS, Picci P.

J Bone Joint Surg Br. 2007 Sep;89(9):1229-33.

PMID:
17905963
7.

Interactomic approach for evaluating nucleophosmin-binding proteins as biomarkers for Ewing's sarcoma.

Haga A, Ogawara Y, Kubota D, Kitabayashi I, Murakami Y, Kondo T.

Electrophoresis. 2013 Jun;34(11):1670-8. doi: 10.1002/elps.201200661.

PMID:
23483572
8.

Factors affecting survival outcomes of patients with non-metastatic Ewing's sarcoma family tumors in the spine: a retrospective analysis of 63 patients in a single center.

Wan W, Lou Y, Hu Z, Wang T, Li J, Tang Y, Wu Z, Xu L, Yang X, Song D, Xiao J.

J Neurooncol. 2017 Jan;131(2):313-320. doi: 10.1007/s11060-016-2295-6. Epub 2016 Oct 17.

PMID:
27752884
9.

Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group.

Cotterill SJ, Ahrens S, Paulussen M, Jürgens HF, Voûte PA, Gadner H, Craft AW.

J Clin Oncol. 2000 Sep;18(17):3108-14.

PMID:
10963639
10.

[Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].

Peng RJ, Sun XF, Xiang XJ, Zhen ZJ, Ling JY, Tong GL, Xia Y, Xu GC, Jiang WQ.

Ai Zheng. 2009 Dec;28(12):1304-9. Chinese.

PMID:
19958626
11.
12.

Periosteal Ewing's sarcoma.

Kolár J, Zídková H, Matĕjovsky Z, Povýsil C, Kolín J, Beran J.

Rofo. 1989 Feb;150(2):179-82.

PMID:
2537514
13.

Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.

Yildiz I, Sen F, Ekenel M, Darendeliler E, Bavbek S, Agaoglu F, Ozger H, Eralp L, Bilgic B, Basaran M.

In Vivo. 2014 May-Jun;28(3):403-9.

PMID:
24815845
14.

Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.

Knowles HJ, Schaefer KL, Dirksen U, Athanasou NA.

BMC Cancer. 2010 Jul 16;10:372. doi: 10.1186/1471-2407-10-372.

15.

Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.

Dramis A, Grimer RJ, Malizos K, Tillman RM, Jeys L, Carter LR.

Acta Orthop Belg. 2016 Aug;82(2):216-221.

PMID:
27682283
16.

Notch signalling is off and is uncoupled from HES1 expression in Ewing's sarcoma.

Bennani-Baiti IM, Aryee DN, Ban J, Machado I, Kauer M, Mühlbacher K, Amann G, Llombart-Bosch A, Kovar H.

J Pathol. 2011 Nov;225(3):353-63. doi: 10.1002/path.2966. Epub 2011 Aug 24.

PMID:
21984123
17.

Phosphoinositide 3-hydroxide kinase blockade enhances apoptosis in the Ewing's sarcoma family of tumors.

Toretsky JA, Thakar M, Eskenazi AE, Frantz CN.

Cancer Res. 1999 Nov 15;59(22):5745-50.

18.

Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.

Ren C, Ren T, Yang K, Wang S, Bao X, Zhang F, Guo W.

J Exp Clin Cancer Res. 2016 Mar 11;35:44. doi: 10.1186/s13046-016-0321-3.

19.

Interferon-gamma sensitizes resistant Ewing's sarcoma cells to tumor necrosis factor apoptosis-inducing ligand-induced apoptosis by up-regulation of caspase-8 without altering chemosensitivity.

Lissat A, Vraetz T, Tsokos M, Klein R, Braun M, Koutelia N, Fisch P, Romero ME, Long L, Noellke P, Mackall CL, Niemeyer CM, Kontny U.

Am J Pathol. 2007 Jun;170(6):1917-30.

20.

Osteosarcoma with small cells simulating Ewing's tumor.

Sim FH, Unni KK, Beabout JW, Dahlin DC.

J Bone Joint Surg Am. 1979 Mar;61(2):207-15.

PMID:
284009

Supplemental Content

Support Center